
CCL2 - Wikipedia
The chemokine (C-C motif) ligand 2 (CCL2) is also referred to as monocyte chemoattractant protein 1 (MCP1) and small inducible cytokine A2. CCL2 is a small cytokine that belongs to the CC chemokine family.
More Than Just Attractive: How CCL2 Influences Myeloid Cell …
Emerging evidence shows that it can impact leukocyte behavior, influencing adhesion, polarization, effector molecule secretion, autophagy, killing, and survival. The direction of these CCL2-induced responses is context dependent and, in some cases, synergistic with other inflammatory stimuli.
Bad Cancer ISGs in Immunotherapy — Andy Minn Lab at UPenn
Increase in NFkB inflammatory cytokines such as CCL2 and CXCL1 that support the development of suppressive myeloid cells. This can create an immunosuppressive tumor microenvironment (TME). Enhanced cell survival that makes cancer cells difficult to kill, particularly by immune cells.
Regulation of macrophage IFNγ-stimulated gene expression by …
Jan 1, 2023 · Here, we show that the closely related Cited1 is an ISG, which is expressed in a STAT1-dependent manner, and that IFNγ stimulates the nuclear accumulation of CITED1 protein. In contrast to CITED2, ectopic CITED1 enhanced the expression of a subset of ISGs, including Ccl2, Ifit3b, Isg15 and Oas2.
CCL2 in the Tumor Microenvironment - PubMed
CCL2 plays a role in recruiting tumor-associated macrophages (TAMs), which adopt a pro-tumorigenic phenotype and support cancer cell survival, facilitate tumor cell invasion, and promote angiogenesis.
CC Chemokine Ligand-2: A Promising Target for Overcoming …
CC chemokine ligand-2 (CCL2), a proinflammatory chemokine that mediates chemotaxis of multiple immune cells, plays a crucial role in the tumor microenvironment (TME) and promotes tumorigenesis and development.
IFI35 limits antitumor immunity in triple-negative breast cancer via ...
Jan 12, 2024 · Mechanistically, RNA-sequencing reveals that IFI35 promotes CCL2 secretion, resulting in the remodeling of TNBC immune microenvironment. Ablation of IFI35 promotes the infiltration of effector CD8 + T cells, and thereby sensitizes TNBC to anti-PD-1 immunotherapy.
Frontiers | CCL2: An important cytokine in normal and pathological ...
Jan 6, 2023 · In this review, we concentrate on CCL2 expression at the maternal-fetal interface, as well as its precise regulatory mechanisms and classic signaling pathways, to reveal the multidimensional aspects of CCL2 in pregnancy.
IκBζ Is a Transcriptional Key Regulator of CCL2/MCP-1
May 1, 2013 · To investigate whether expression of Ccl2 and CCL2 secretion were generally impaired in IκBζ-deficient cells, we analyzed the kinetics of Nfkbiz and Ccl2 induction in IFN-γ–activated PMΦ in response to several proinflammatory stimuli, including PGN, …
Insights into CC Chemokine Ligand 2/Chemokine Receptor 2 …
Jun 1, 2017 · Chemokine ligand 2 (CCL2), also known as monocyte chemoattractant protein 1 (MCP-1), is a chemokine that recruits immune cells to inflammatory sites by interacting with G protein-coupled receptor CCR2.